Latest round: IPO. David Fischel is the Chairman and CEO of Stereotaxis, a publicly traded surgical robotics company listed on the NYSE under ticker STXS.
David Fischel is the Chairman and CEO of Stereotaxis, a publicly traded surgical robotics company listed on the NYSE under ticker STXS that develops robots for minimally invasive heart surgeries. He leads the St. Louis-based company, which has approximately 150 employees and whose robots are used in about 100 hospitals globally. Fischel has been identified as the CEO of Stereotaxis in public interviews and company profiles.
Full founder directory · Investor directory · Company funding database · Fundraising library